Diagnosis and management of Duchenne muscular dystrophy, part 1: diagnosis, and pharmacological and psychosocial managementK. Bushby, Carolyn M. Constantin, Richard S. Finkel et al.|The Lancet Neurology|2009Cited by 2k
Diagnosis and management of Duchenne muscular dystrophy, part 2: implementation of multidisciplinary careK. Bushby, Carolyn M. Constantin, Richard S. Finkel et al.|The Lancet Neurology|2009Cited by 1.2k
Assessment of Systemic Delivery of rAAVrh74.MHCK7.micro-dystrophin in Children With Duchenne Muscular DystrophyJerry R. Mendell, Louise R. Rodino‐Klapac, Kathleen Church et al.|JAMA Neurology|2020Cited by 387
G.P.13.05 The diagnosis and management of Duchenne muscular dystrophy: Internationally generated care recommendationsK. Bushby, Carolyn M. Constantin, David J. Birnkrant et al.|Neuromuscular Disorders|2009Cited by 1
EP.83Design of a Phase 2/3 randomized controlled trial of suvodirsen (WVE-210201) in patients with Duchenne muscular dystrophy amenable to exon 51 skippingKathryn R. Wagner, Michael Panzara, M. Eagle et al.|Neuromuscular Disorders|2019Cited by 1